封面
市场调查报告书
商品编码
1702362

全球生物电医学市场 - 2025-2033

Global Bioelectric Medicine Market - 2025-2033

出版日期: | 出版商: DataM Intelligence | 英文 165 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球生物电医疗市场规模达到 313.4 亿美元,预计到 2033 年将达到 2,355.5 亿美元,在 2025-2033 年预测期内的复合年增长率为 22.3%。

生物电医学,也称为电疗法,是一门利用电脉衝治疗心律不整、癫痫、帕金森氏症和慢性疼痛等疾病的医学科学。它涉及刺激特定神经或组织的植入式装置,为神经病学、心臟病学和其他治疗领域的药物治疗提供创新的替代方案。该技术整合了神经调节和生物工程,提高了患者的治疗效果。

市场动态:

驾驶员和约束装置

慢性病盛行率不断上升

生物电医学市场的发展受到心血管疾病、神经系统疾病和慢性疼痛等慢性疾病日益流行的推动,以及人口老化和心律不整、癫痫和帕金森氏症病例的增加,而神经调节技术的进步和电医学应用的不断扩大又推动了生物电医学市场的发展。例如,国际糖尿病联合会报告称,2021年,全球有5.366亿成年人(即十分之一的人口)患有糖尿病,预计到2030年这一数字将上升到6.428亿,到2045年将上升到7.837亿,尤其是在中低收入国家,这凸显了对糖尿病护理药物和设备的迫切需求。

因此,糖尿病盛行率的上升推动了对包括生物电医学在内的先进治疗方案的需求。生物电疗法,如神经调节装置,为控制併发症和改善患者预后提供了一个有希望的替代方法,特别是在中低收入国家。

设备相关併发症的风险

生物电医学市场面临挑战,因为潜在的设备相关併发症,如感染、故障和免疫反应。植入式生物电设备需要手术操作,有术后感染、电极移位和硬体故障的风险。长期使用可能需要更换设备,增加医疗成本和患者担忧,可能限制生物电医学的广泛应用。

目录

第一章:市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第二章:高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的程式码片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第三章:动态

  • 影响因素
    • 驱动程式
      • 慢性病盛行率不断上升
      • 科技进步的兴起
    • 限制
      • 设备相关併发症的风险
      • 严格的监管要求和审批延迟
    • 机会
      • 研发投资增加
    • 影响分析

第四章:战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的既定领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析:最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第五章:依产品类型

  • 植入式装置
    • 起搏器
    • 植入式心臟復律去颤器
    • 人工耳蜗
    • 脊髓刺激器
    • 深部脑部刺激器
    • 迷走神经刺激器
    • 荐神经刺激器
  • 非侵入式设备

第六章:按应用

  • 心律不整
  • 感音神经性听损
  • 癫痫
  • 帕金森氏症
  • 其他的

第 7 章:按最终用户

  • 医院
  • 门诊手术中心
  • 其他的

第八章:区域市场分析与成长机会

  • 北美洲
    • 关键区域特定动态
      • 我们
      • 加拿大
      • 墨西哥
  • 欧洲
    • 关键区域特定动态
      • 德国
      • 英国
      • 法国
      • 西班牙
      • 义大利
      • 欧洲其他地区
  • 拉丁美洲
    • 关键区域特定动态
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地区
  • 亚太
    • 关键区域特定动态
      • 中国
      • 印度
      • 日本
      • 韩国
      • 亚太其他地区
  • 中东和非洲
    • 关键区域特定动态

第九章:竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十章:公司简介

  • Medtronic Plc
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 併购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT分析
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • Biotronik SE & Co. KG
  • Nevro Corp.
  • Cochlear Ltd.
  • electroCore, Inc.
  • Axonics, Inc.
  • NeuroPace, Inc.

第 11 章:假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 12 章:附录

简介目录
Product Code: MD9443

The global bioelectric medicine market reached US$ 31.34 billion in 2024 and is expected to reach US$ 235.55 billion by 2033, growing at a CAGR of 22.3% during the forecast period 2025-2033.

Bioelectric medicine, also known as electroceuticals, is a medical science that uses electrical impulses to treat diseases like arrhythmia, epilepsy, Parkinson's, and chronic pain. It involves implantable devices that stimulate specific nerves or tissues, offering innovative alternatives to pharmaceutical treatments in neurology, cardiology, and other therapeutic areas. This technology integrates neuromodulation and bioengineering, enhancing patient outcomes.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Chronic Diseases

The bioelectric medicine market is driven by the increasing prevalence of chronic diseases like cardiovascular disorders, neurological conditions, and chronic pain, as well as the aging population and increasing cases of arrhythmia, epilepsy, and Parkinson's disease, driven by advancements in neuromodulation technology and expanding electroceutical applications. For instance, The International Diabetes Federation reports that in 2021, 536.6 million adults, or 1 in 10 people, were living with diabetes, with the number predicted to rise to 642.8 million by 2030 and 783.7 million by 2045, particularly in low- and middle-income countries, highlighting the urgent need for diabetes care drugs and devices.

Hence, the increasing diabetes prevalence is driving demand for advanced treatment solutions, including bioelectric medicine. Bioelectric therapies, like neuromodulation devices, offer promising alternatives for managing complications and improving patient outcomes, especially in low- and middle-income countries.

Risk of Device-Related Complications

The bioelectric medicine market faces challenges due to potential device-related complications like infections, malfunctions, and immune responses. Implantable bioelectric devices require surgical procedures, posing risks of post-operative infections, electrode displacement, and hardware failure. Long-term use may require device replacements, increasing healthcare costs and patient concerns, potentially limiting bioelectric medicine's widespread adoption.

Segment Analysis

The global bioelectric medicine market is segmented based on product type, application, end-user and region.

Product Type:

The implantable devices from the product type segment are expected to dominate the bioelectric medicine market with the highest market share

Implantable devices are medical instruments that are surgically placed inside the body to deliver targeted electrical stimulation for therapeutic purposes. They, including pacemakers, ICDs, deep brain stimulators, spinal cord stimulators, and vagus nerve stimulators, work by modulating neural or muscular activity to restore normal physiological functions. They are widely used in treating cardiovascular, neurological, and chronic pain conditions, offering long-term solutions with minimal reliance on pharmaceuticals.

The implantable devices segment is driven by the rise in chronic diseases, particularly cardiovascular and neurological disorders. Technological advancements like miniaturization, wireless connectivity, and rechargeable battery systems are enhancing device efficiency and patient convenience. Growing geriatric populations, expanding healthcare infrastructure, and increased awareness about neuromodulation therapies further boost market growth. Favorable reimbursement policies and research investments contribute to this growth.

For instance, in October 2024, a Carnegie Mellon University-led team was awarded up to $42 billion by ARPA-H to develop implantable, cell-based bioelectric devices for real-time disease monitoring and patient-specific therapy. This is part of the ARPA-H REACT program, which aims to improve chronic disease management through implantable bioelectronic devices.

Geographical Analysis

North America is expected to hold a significant position in the bioelectric medicine market with the highest market share

North America leads the global bioelectric medicine market due to product launches, advanced healthcare infrastructure, innovative medical technologies, and key market players. The region's high prevalence of chronic diseases, favorable reimbursement policies, and investments in neuromodulation research drive demand for implantable bioelectric devices like pacemakers and neurostimulators. Additionally, rising healthcare expenditure and growing awareness of electroceutical therapies contribute to the expanding use of bioelectric medicine in North America.

For instance, in June 2024, electroCore, Inc., a bioelectronic medicine and wellness company, announced the Commercial Off the Shelf (COTS) availability of the next generation TAC-STIM, a non-invasive vagus nerve stimulator designed in partnership with the US military for active-duty military use.

Competitive Landscape

The major global players in the bioelectric medicine market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Biotronik SE & Co. KG, Nevro Corp., Cochlear Ltd, electroCore, Inc., Axonics, Inc., and NeuroPace, Inc., among others.

Key Developments

  • In July 2023, Boston Scientific Corporation received FDA approval for its Vercise Neural Navigator 5 software, which is designed to be used alongside Vercise Genus deep brain stimulation systems. This software offers clinicians practical data for treating Parkinson's disease or essential tremor, allowing them to efficiently program the DBS system.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global bioelectric medicine market report delivers a detailed analysis with 62 key tables, more than 53 visually impactful figures and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Prevalence of Chronic Diseases
      • 3.1.1.2. Rise in Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Risk of Device-Related Complications
      • 3.1.2.2. Stringent Regulatory Requirements and Approval Delays
    • 3.1.3. Opportunity
      • 3.1.3.1. Rise in Investment in Research and Development
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Implantable Devices*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Pacemakers
    • 5.2.4. ICDs
    • 5.2.5. Cochlear Implants
    • 5.2.6. Spinal Cord Stimulators
    • 5.2.7. Deep Brain Stimulators
    • 5.2.8. Vagus Nerve Stimulators
    • 5.2.9. Sacral Nerve Stimulatord
  • 5.3. Non-Invasive Devices

6. By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Arrhythmia*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Sensorineural Hearing Loss
  • 6.4. Epilepsy
  • 6.5. Parkinson's Disease
  • 6.6. Others

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Others

8. Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Medtronic Plc*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Abbott Laboratories
  • 10.3. Boston Scientific Corporation
  • 10.4. LivaNova PLC
  • 10.5. Biotronik SE & Co. KG
  • 10.6. Nevro Corp.
  • 10.7. Cochlear Ltd.
  • 10.8. electroCore, Inc.
  • 10.9. Axonics, Inc.
  • 10.10. NeuroPace, Inc.

LIST NOT EXHAUSTIVE

11. Assumptions and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us